Literature DB >> 12499627

Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathy.

Go Hiasa1, Mareomi Hamada, Yuji Shigematsu, Yuji Hara, Tomoaki Ohtsuka, Akiyoshi Ogimoto, Hideyuki Saeki, Jun Suzuki, Tsuyoshi Matsunaka, Hironobu Hamada, Takafumi Okura, Kunio Hiwada.   

Abstract

An 18-year-old male patient with biventricular hypertrophic obstructive cardiomyopathy (HOCM) had successful reduction of the pressure gradients by cibenzoline. At 11 months after birth, he was first diagnosed with cardiac murmurs and by the age of 5 years, he was diagnosed with subpulmonic infundibular stenosis with a pressure gradient of 10 mmHg by cardiac catheterization. At the age of 14, re-catherterization revealed hypertrophic cardiomyopathy with isolated obstruction of the right ventricular outflow tract, with a pressure gradient of 70 mmHg, but no obstruction in the left ventricle. He began daily treatment with 30 mg propranolol. At the age of 18, he was admitted for cardiac evaluation. An echocardiogram revealed left mid-ventricular and subpulmonic obstructions associated with pressure gradients of 88 mmHg and 65 mmHg, respectively. A single oral dose of 200 mg of cibenzoline decreased the pressure gradients in the left and right ventricles (38 mmHg and 36 mmHg, respectively). He was then given 300 mg daily of cibenzoline, and both pressure gradients remained low without any complications 8 months later at the time of discharge.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499627     DOI: 10.1253/circj.66.1173

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  2 in total

1.  Effect of cibenzoline on biventricular pressure gradients in a pediatric patient with hypertrophic obstructive cardiomyopathy.

Authors:  Takamichi Ishikawa; Satoru Iwashima; Takehiko Ohzeki
Journal:  Pediatr Cardiol       Date:  2010-02-07       Impact factor: 1.655

2.  Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy.

Authors:  Shanshan Zhai; Haitao Xu; Chaomei Fan; Yinjian Yang; Fei Hang; Xiying Guo; Hongyue Wang; Fujian Duan; Jun Yan
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.